<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="https://www.dolcera.com/wiki/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>https://www.dolcera.com/wiki/index.php?action=history&amp;feed=atom&amp;title=Sanofi-Aventis_Animal_Health</id>
		<title>Sanofi-Aventis Animal Health - Revision history</title>
		<link rel="self" type="application/atom+xml" href="https://www.dolcera.com/wiki/index.php?action=history&amp;feed=atom&amp;title=Sanofi-Aventis_Animal_Health"/>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Sanofi-Aventis_Animal_Health&amp;action=history"/>
		<updated>2026-04-25T06:53:47Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.24wmf12</generator>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Sanofi-Aventis_Animal_Health&amp;diff=9676&amp;oldid=prev</id>
		<title>Abhay.goel at 13:57, 16 September 2011</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Sanofi-Aventis_Animal_Health&amp;diff=9676&amp;oldid=prev"/>
				<updated>2011-09-16T13:57:14Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Go back to [http://dolcera.com/wiki/index.php?title=Veterinary_Vaccines_Market_Report#Company_Snapshot homepage]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;60%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot; colspan = &amp;quot;2&amp;quot;|'''Sanofi-Aventis Animal Health'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot; colspan = &amp;quot;2&amp;quot;|'''Financial Details'''&lt;br /&gt;
|-&lt;br /&gt;
|'''Total Company Revenue in 2010'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$ 30.384 Bn&lt;br /&gt;
|-&lt;br /&gt;
|'''Revenue from Animal Health Market in 2010'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$ 2.635 Bn&lt;br /&gt;
|-&lt;br /&gt;
|'''% of revenue from Animal Health  in 2010'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|8.67%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot; colspan = &amp;quot;2&amp;quot;|'''Segmentwise Revenue Breakup ($ Bn)'''&lt;br /&gt;
|-&lt;br /&gt;
|'''Livestock Vaccines'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|1.021&lt;br /&gt;
|-&lt;br /&gt;
|'''Companion Vaccines'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|1.614&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot; colspan = &amp;quot;2&amp;quot;|'''Number of Major Vaccines (Animal-wise)'''&lt;br /&gt;
|-&lt;br /&gt;
|'''Poultry'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|0&lt;br /&gt;
|-&lt;br /&gt;
|'''Swine'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|0&lt;br /&gt;
|-&lt;br /&gt;
|'''Fish'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|0&lt;br /&gt;
|-&lt;br /&gt;
|'''Sheep'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|0&lt;br /&gt;
|-&lt;br /&gt;
|'''Cattle'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|0&lt;br /&gt;
|-&lt;br /&gt;
|'''Canine'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|3&lt;br /&gt;
|-&lt;br /&gt;
|'''Feline'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|2&lt;br /&gt;
|-&lt;br /&gt;
|'''Equine'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|2&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Mergers and Acquisitions (2009 - 2011)'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Consideration'''&lt;br /&gt;
|-&lt;br /&gt;
|'''Merial Ltd'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$ 4 Bn&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot; colspan = &amp;quot;2&amp;quot;|'''Future Focus Areas'''&lt;br /&gt;
|-&lt;br /&gt;
|'''Veterinary Vaccines under trial'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|0&lt;br /&gt;
|-&lt;br /&gt;
|rowspan = &amp;quot;2&amp;quot;|'''Future Focus Areas of the company in the Veterinary Vaccines Market'''&lt;br /&gt;
|Viral and parasitological vaccines&lt;br /&gt;
|-&lt;br /&gt;
|In pharmaceutical R&amp;amp;D, we have 120 ongoing projects focusing on parasiticides, anti-infectives and internal medicine (endocrine/pain) and performance products. Meanwhile in biological R&amp;amp;D, we have 140 projects in progress focusing on zoonotic and emerging diseases, respiratory diseases, enteric diseases and enabling technologies.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt; &amp;lt;br&amp;gt;&lt;br /&gt;
Go back to [http://dolcera.com/wiki/index.php?title=Veterinary_Vaccines_Market_Report#Company_Snapshot homepage]&lt;/div&gt;</summary>
		<author><name>Abhay.goel</name></author>	</entry>

	</feed>